Dr Raymond Michael Danchak, MD | |
4601 50th St, Suite 112, Lubbock, TX 79414-3513 | |
(806) 785-8000 | |
(806) 792-7174 |
Full Name | Dr Raymond Michael Danchak |
---|---|
Gender | Male |
Speciality | Anesthesiology |
Experience | 41 Years |
Location | 4601 50th St, Lubbock, Texas |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1043272735 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207L00000X | Anesthesiology | J3080 (Texas) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Lubbock Heart Hospital Lp | Lubbock, TX | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Northstar Anesthesia Pa | 7315907128 | 290 |
Great Plains Anesthesia | 8022166297 | 2 |
News Archive
Biologists have determined the three-dimensional structure of an unusual viral enzyme that is required in the assembly of new viruses.
Chindex International, Inc., a leading independent American provider of Western healthcare products and services in the People's Republic of China, today announced results for the second quarter and first half of fiscal 2010, which ended September 30, 2009.
Treatment for heart failure should take into consideration a patient's social determinants of health - their overall living environment, socio-economic status, as well as the needs of unpaid family caregivers, according to two new scientific statements from the American Heart Association, published simultaneously today in the Association's flagship journal Circulation.
The Green Family Foundation (www.greenff.org), a private, non-profit organization dedicated to improving global health and elevating socio-economic conditions, announced today dual commitments benefiting Haiti at the 2009 Clinton Global Initiative.
Johnson & Johnson Pharmaceutical Research & Development, L.L.C., today announced results from the MAGELLAN Phase 3 trial evaluating the investigational oral anticoagulant rivaroxaban for the prevention of venous thromboembolism in hospitalized patients with acute medical illnesses.
› Verified 6 days ago
Entity Name | Northstar Anesthesia Pa |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1912978610 PECOS PAC ID: 7315907128 Enrollment ID: O20041015000685 |
News Archive
Biologists have determined the three-dimensional structure of an unusual viral enzyme that is required in the assembly of new viruses.
Chindex International, Inc., a leading independent American provider of Western healthcare products and services in the People's Republic of China, today announced results for the second quarter and first half of fiscal 2010, which ended September 30, 2009.
Treatment for heart failure should take into consideration a patient's social determinants of health - their overall living environment, socio-economic status, as well as the needs of unpaid family caregivers, according to two new scientific statements from the American Heart Association, published simultaneously today in the Association's flagship journal Circulation.
The Green Family Foundation (www.greenff.org), a private, non-profit organization dedicated to improving global health and elevating socio-economic conditions, announced today dual commitments benefiting Haiti at the 2009 Clinton Global Initiative.
Johnson & Johnson Pharmaceutical Research & Development, L.L.C., today announced results from the MAGELLAN Phase 3 trial evaluating the investigational oral anticoagulant rivaroxaban for the prevention of venous thromboembolism in hospitalized patients with acute medical illnesses.
› Verified 6 days ago
Entity Name | Great Plains Anesthesia |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1750343331 PECOS PAC ID: 8022166297 Enrollment ID: O20090427000415 |
News Archive
Biologists have determined the three-dimensional structure of an unusual viral enzyme that is required in the assembly of new viruses.
Chindex International, Inc., a leading independent American provider of Western healthcare products and services in the People's Republic of China, today announced results for the second quarter and first half of fiscal 2010, which ended September 30, 2009.
Treatment for heart failure should take into consideration a patient's social determinants of health - their overall living environment, socio-economic status, as well as the needs of unpaid family caregivers, according to two new scientific statements from the American Heart Association, published simultaneously today in the Association's flagship journal Circulation.
The Green Family Foundation (www.greenff.org), a private, non-profit organization dedicated to improving global health and elevating socio-economic conditions, announced today dual commitments benefiting Haiti at the 2009 Clinton Global Initiative.
Johnson & Johnson Pharmaceutical Research & Development, L.L.C., today announced results from the MAGELLAN Phase 3 trial evaluating the investigational oral anticoagulant rivaroxaban for the prevention of venous thromboembolism in hospitalized patients with acute medical illnesses.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Raymond Michael Danchak, MD Po Box 93882, Lubbock, TX 79493-3882 Ph: (806) 785-8000 | Dr Raymond Michael Danchak, MD 4601 50th St, Suite 112, Lubbock, TX 79414-3513 Ph: (806) 785-8000 |
News Archive
Biologists have determined the three-dimensional structure of an unusual viral enzyme that is required in the assembly of new viruses.
Chindex International, Inc., a leading independent American provider of Western healthcare products and services in the People's Republic of China, today announced results for the second quarter and first half of fiscal 2010, which ended September 30, 2009.
Treatment for heart failure should take into consideration a patient's social determinants of health - their overall living environment, socio-economic status, as well as the needs of unpaid family caregivers, according to two new scientific statements from the American Heart Association, published simultaneously today in the Association's flagship journal Circulation.
The Green Family Foundation (www.greenff.org), a private, non-profit organization dedicated to improving global health and elevating socio-economic conditions, announced today dual commitments benefiting Haiti at the 2009 Clinton Global Initiative.
Johnson & Johnson Pharmaceutical Research & Development, L.L.C., today announced results from the MAGELLAN Phase 3 trial evaluating the investigational oral anticoagulant rivaroxaban for the prevention of venous thromboembolism in hospitalized patients with acute medical illnesses.
› Verified 6 days ago
Michael Lynn Strickland, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 5828 Erskine St, Lubbock, TX 79416 Phone: 806-795-2726 Fax: 806-795-2726 | |
Dr. Byron L Brown, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 3508 22nd Pl, Lubbock, TX 79410 Phone: 806-799-1485 Fax: 806-799-8132 | |
Suzanne N. Northcutt, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 3601 4th St, Ste 1c282, Lubbock, TX 79430 Phone: 806-743-2981 Fax: 806-743-2984 | |
Rajinder Sabar, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 2412 50th St, Lubbock, TX 79412 Phone: 806-744-7223 Fax: 806-740-3325 | |
Dr. William Jewell Davis, M.D. Anesthesiology Medicare: Medicare Enrolled Practice Location: 6202 Iola Ave Ste 101, Lubbock, TX 79424 Phone: 806-799-2093 Fax: 806-783-0277 | |
Dr. Corey Jay Haggard, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 4640 N Loop 289, Lubbock, TX 79416 Phone: 806-794-1223 Fax: 806-589-0216 |